Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Week Comparison of DuoTrav and Xalacom at 24 Hours Post-Dose in the Treatment of Open-Angle Glaucoma (the DVX Study)

NCT00887029 is registered in ClinicalTrials.gov with Ophthalmic Consultants Centres, Canada as lead sponsor.

NCT NCT00887029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00887029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Week Comparison of DuoTrav and Xalacom at 24 Hours Post-Dose in the Treatment of Open-Angle Glaucoma (the DVX Study)
Lead sponsor
Ophthalmic Consultants Centres, Canada
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
November 30, 2009
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open-angle glaucoma